Boston Partners’s Dorman Products DORM Stock Holding History

Boston Partners’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-11,785	Closed	-$805K	–	725
2018 Q2	$805K	Buy	+11,785	New	+$794K	﹤0.01%	757

Other funds holding DORM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Boston Partners's DORM Position: Q3 2018 in Review

Boston Partners sold out of Dorman Products (DORM) in Q3 2018, closing a stake of 11,785 shares — an estimated $805K sold.

Boston Partners first reported a position in DORM in Q2 2018 and held it in 1 quarter. The position peaked at $805K in Q2 2018. 229 funds tracked by Wall St. Rank hold DORM as of Q3 2018.

Boston Partners reported no remaining Dorman Products position as of Q3 2018 after selling out during the quarter.
Boston Partners sold 11,785 Dorman Products shares in Q3 2018, an estimated $805K.
Boston Partners first reported a position in Dorman Products in Q2 2018 and held it in 1 quarter.
Boston Partners's Dorman Products position peaked at $805K in Q2 2018.
229 funds tracked by Wall St. Rank held Dorman Products as of Q3 2018.

Based on Boston Partners's 13F filing for Q3 2018, filed 14 Nov 2018.